<DOC>
	<DOCNO>NCT01448850</DOCNO>
	<brief_summary>The purpose study evaluate effect MEDI8968 rate moderate severe acute exacerbation chronic obstructive pulmonary disease ( AECOPD ) adult subject symptomatic , moderate severe COPD ( Global Initiative Chronic Obstructive Lung Disease - GOLD stage II-IV ) receive standard maintenance therapy underlie disease condition .</brief_summary>
	<brief_title>A Study Evaluate Efficacy MEDI8968 Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>A Phase 2 double-blind , placebo-controlled study evaluate efficacy MEDI8968 Chronic Obstructive Pulmonary Disease . The study screen phase 23 day , treatment phase Week 1 53 follow-up phase Week 53 69 . Participants receive either MEDI8968 600 milligram ( mg ) intravenous ( IV ) infusion Day 1 follow 300 mg injection subcutaneously ( SC ) every 4 week Week 53 match placebo fashion . Participants primarily assess incidence rate moderate severe acute exacerbation chronic obstructive pulmonary disease ( AECOPD ) . Safety monitor throughout study .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Age 45 75 year Predicted ( Global Initiative Chronic Obstructive Lung Disease [ GOLD ] stage II , III , IV ) Screening History previous acute exacerbation chronic obstructive pulmonary disease ( AECOPD ) 12 month prior Screening Clinically stable free AECOPD 8 week prior Day 1 Current smoker exsmoker tobacco history equal ( &gt; = ) 10 packyears . Past present disease disorder , Significant unstable ischemic heart disease etc Known history allergy reaction component investigational manufacturing product ( IMP ) Past current malignancy within past 5 year Subjects chest xray Computed Tomography ( CT ) scan suggestive malignancy tuberculosis ( TB ) . Use immunosuppressive medication receipt biologic agent .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease ( COPD )</keyword>
	<keyword>MEDI8968</keyword>
</DOC>